September 2017 FDA Recall Drug by Genentech, Inc.
D-1175-2017 - Non-Sterility
This Class I drug recall was voluntarily initiated by Genentech, Inc. on September 5, 2017 for the product Drug. The FDA reported the reason for recall as non-sterility. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1175-2017
Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.
09-05-2017
09-27-2017
16,882
Recall Profile & Regulatory Data
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Genentech, Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the USA
01-11-2019
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device. Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27
Batch or Lot Expiration Information
Lot# 3128243, 3141239, EXP. 9/30/2018; 3166728, EXP. 2/28/2019.